Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

There's no better drive-thru porch-sipper than McDonald's Sweet Tea, but you can brew a copycat version with plenty of sugar ...

The pharmaceutical giant said multiple entities were still marketing and selling unbranded versions of its drug despite U.S.

China is now well-known for its "copycat syndrome," particularly regarding its replicas of world-famous monuments, the originals of which are considered symbols of cultural status reflecting an empire ...

McDonald’s slow return of its Snack Wrap paved the way for one of the strangest battles in the ongoing fast-food war.

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...

Investors knocked $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Sony’s beef lies with Tencent’s upcoming game Light of Motiram, a title still in development but already stirring up ...

LONDON (Reuters) -Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales growth and sliding share price. He first will need to win ...